Gerard Brophy - 20 Feb 2022 Form 4 Insider Report for Avantor, Inc. (AVTR)

Role
EVP, Biopharma Production
Signature
/s/ Scott Baker, as Attorney-in-Fact
Issuer symbol
AVTR
Transactions as of
20 Feb 2022
Net transactions value
-$104,448
Form type
4
Filing time
22 Feb 2022, 16:27:56 UTC
Previous filing
05 Jan 2022
Next filing
25 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTR Common Stock Tax liability $104,448 -3,072 -2.3% $34.00 128,240 20 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.